- Report
- May 2021
- 50 Pages
China
From €2379EUR$2,600USD£2,067GBP
- Report
- February 2024
- 90 Pages
Europe
From €4347EUR$4,750USD£3,777GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €458EUR$500USD£398GBP
Diprivan (propofol) is a sedative-hypnotic drug used in anesthetic practice. It is a short-acting intravenous anesthetic agent that produces a rapid onset of sedation and amnesia. It is commonly used for induction and maintenance of general anesthesia, as well as for sedation of mechanically ventilated patients. Diprivan is also used for procedural sedation in the emergency department and intensive care unit. It is a popular choice for anesthetic drugs due to its rapid onset and short duration of action.
The Diprivan market is highly competitive, with a number of companies offering the drug. Some of the major players in the market include AstraZeneca, Fresenius Kabi, Hospira, Mylan, and Teva Pharmaceuticals. Show Less Read more